1Edwards JE, Bodey GP, Bowden RA, et al. International conference for the development of a consensus on the management and prevention of severe candidal infectious[J]. Clin Infect Dis, 1997,25:43-59. 被引量：1
2National Committee for Clinical Laboratory Standards.Reference method for broth dilution antifungal susceptibility of yeast ; Approved standard M27A[ S]. Lancaster Avenue, villanova, pennsylvania: NCCLS, 1997.1-12. 被引量：1
3Ptaller MA, Jones RV, Doern GV, et al. Bloodstream infectious due to candida species: SENTRY antimicrobial surveillance program in North America and Latin America[ J ]. Antimicrob Agents Chemother, 2000,44 :747-751. 被引量：1
4Schwab U, Chemomas F, Larcom L, et al. Molecular typing and fluconazole susceptibility of urinary Candida glabrata isolates from hospitalized patients [J ]. Diag Microbiol Infect Dis, 1997,29 : 11-17. 被引量：1
6Ohya S,Fukuoka T,Masuda N,et al.Microbiological evaluation of panipenem/betamipron,a new parenterally active carlapenem V.increase in susceptibility of pseudomonas aeruginosa to panipenem in low.amino-acid media.Chemo Therapy,1991,39(S-3):132 被引量：1
7Levy SB.The Challenge of antibiotic resistance[J].Scientific American,1998,278:46-53 被引量：1
8Jones RN,Pfaller MA.Bacterial resistance: A worldwide problem[J].Diagn.Microbiol Infect Dis,1998,31:379-388 被引量：1
9Williams RJ,Ryan MJ.Surveillance of antimicrobial resistance-an international perspective[J].Br Med J,1998,317:651 被引量：1
10Am Society Microbiol.Report of the ASM task force on antibiotic resistance[J].Antimicrob Agents,Chemother,1995,Supplement: 1-23 被引量：1
